Incyte

Aktienkurs
108.39
Täglich Wechseln
5.63 5.48%
Monatlich
-1.97%
Jährlich
46.22%
Q1 Prognose
105.06




Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Amgen USD 5.91B 2.31B 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Incyte USD 581.52M 358.87M 2025-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Moderna USD -208M 552M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Novartis USD 5.88B 290M 2025-09
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Incyte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.